Fluorometric Determination of 2′-β-Fluoro-2′,3′-dideoxyadenosine 5′-Triphosphate, the Active Metabolite of a New Anti-Human Immunodeficiency Virus Drug, in Human Lymphocytes
✍ Scribed by Fang Dai; James A. Kelley; Heping Zhang; Nancy Malinowski; Mark F. Kavlick; Jill Lietzau; Lauri Welles; Robert Yarchoan; Harry Ford Jr.
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 104 KB
- Volume
- 288
- Category
- Article
- ISSN
- 0003-2697
No coin nor oath required. For personal study only.
✦ Synopsis
A sensitive precolumn derivatization method has been developed to measure the 5-triphosphate of 2-fluoro-2,3-dideoxyadenosine (F-ddA, lodenosine), a new anti-HIV drug, in human lymphocytes by HPLC using fluorescence detection. Reaction of chloroacetaldehyde with F-ddA triphosphate in extracts from human lymphocytes produces a highly fluorescent etheno adduct. This derivative is then separated and quantitated by reverse-phase paired-ion chromatography. Degradation of natural nucleic acid ribosides, such as ATP, using periodate oxidation simplifies the chromatogram and minimizes interference with detection of the target analyte. This method, modeled using cultured MOLT-4 T-lymphocytes, achieves a linear detector response for peak area measurements over the range 2.5 to 22.5 pmol (50 -450 nM using 50 l sample). Analyte recovery is greater than 90%, and the method achieves a limit of detection and limit of quantitation of 1.4 and 2.5 pmol per HPLC injection (50 l sample containing cellular extract from 2.5 ؋ 10 6 cells), respectively. Application of this method to measure F-ddATP in peripheral blood mononuclear cells from HIV-infected patients treated with F-ddA at 3.2 mg/kg twice daily for 22 days shows F-ddATP levels which range from 1.5 to 3.5 pmol/10 6 cells.